Local Excision for Organ Preservation in Early REctal Cancer With No Adjuvant Treatment

Recruiting Observational Study
Rectal Cancer Rectum Neoplasm
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
145 (estimated)
Sponsor
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Rectal cancer is one of the most frequent malignant tumors nowadays. There are several possible treatment options including chemotherapy, radiotherapy and surgery. Surgery for early stage rectal cancer can be either a radical surgery (RS) or a local excision (LE). A radical surgery removes the rectum including the tumor and the lymph nodes through which it spreads, improving survival but with a p…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients age 18 years or older. * Histologic proof of infiltrating rectal adenocarcinoma. or * Preoperative biopsy compatible with rectal adenoma or intramucous adenocarcinoma with endoscopic or radiological suspicion of infiltrating adenocarcinoma. 1. Endoscopic criteria: …
Contacts

Rodrigo Tovar Perez, MD

+34915202200

triallorena@gmail.com

CONTACT

Carlos Cerdán Santacruz, PhD

+34915202200

carlos.cerdan@salud.madrid.org

CONTACT